Predicting differential antigen-antibody contact regions based on solvent accessibility

Journal of Protein Chemistry

Volumn 16, Issue 6, 1997, Pages 607-618

  Lebeda, Frank J ^a   Olson, Mark A ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

Botulinum neurotoxin; Neural network algorithm; Neutralizing determinant; Type specific antibody; Vaccine

Indexed keywords

ALGORITHM; AMINO ACID SEQUENCE; ANTIBODY COMBINING SITE; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; ARTICLE; ARTIFICIAL NEURAL NETWORK; MATHEMATICAL ANALYSIS; PROTEIN SECONDARY STRUCTURE;

ALGORITHMS; ANTIGEN-ANTIBODY REACTIONS; BOTULINUM TOXINS; EPITOPES; NEURAL NETWORKS (COMPUTER); PROTEIN STRUCTURE, SECONDARY; SOLVENTS; TETANUS TOXIN;

AVES;

EID: 0030810894     PISSN: 02778033     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026370807586     Document Type: Article

References (43)

1. Atassi, M. Z. (1978). Precise determination of the entire antigenic structure of lysozyme, Immunochemistry 15, 909-936.
2. Atassi, M. Z., and Young, J. A. (1985). Discovery and implications of the immunogenicity of free small synthetic peptides, CRC Crit. Rev. Immunol. 5, 387-409.
3. Atassi, M. Z., Dolimbek, B. Z., Hayakari, M., Middlebrook, J. L., Whitney, B., and Ishima, M. (1996). Mapping of the antibody-binding regions on botulinum neurotoxin H-chain domain 855-1296 with antitoxin antibodies from three host species, J. Protein Chem. 15, 691-700.
4. Bizzini, B., Akert, K., Glicksman, M., and Grob, P. (1980). Preparation of conjugates using two tetanus toxin derived fragments: Their binding to gangliosides and isolated synaptic membranes and their immunological properties, Toxicon 18, 561-572.
5. Branden, B. C., Souchon, H., Eiselé, J.-L., Bentley, G. A., Bhat, T. N., Navaza, J., and Poljak, R. J. (1994). Three-dimensional structures of the free and the antigen-complexed Fab from monoclonal anti-lysozyme antibody D44.1, J. Mol. Biol. 243, 767-781.
6. Chitarra, V., Alzari, P. M., Bentley, G. A., Bhat, T. N., Eiselé, J.-L., Houdusse, A., Lescar, J., Souchon, H., and Poljak, R. J. (1993). Three-dimensional structure of a heteroclitic antigen-antibody cross-reaction complex, Proc. Natl. Acad. Sci. USA 90, 7711-7715.
7. Clayton, M. A., Clayton, J. M., Brown, D. R., and Middlebrook, J. L. (1995). Protective vaccination with a recombinant fragment of Clostridium botulinum neurotoxin serotype A expressed from a synthetic gene in Escherichia coli, Infect. Immunol. 63, 2738-2742.
8. Dertzbaugh, M. T., and West, M. W. (1995). Identification of protective domains of botulinum neurotoxin serotype A, in First International Conference on the Molecular Genetics and Pathogenesis of the Clostridia, p. 12.
9. Dertzbaugh, M. T., and West, M. W. (1996). Mapping of protective and cross-reactive domains of the type A neurotoxin of Clostridium botulinum, Vaccine 14, 1538-1544.
10. Devereux, J., Haeberli, P., and Smithies, O. (1984). A comprehensive set of sequence analysis programs for the VAX, Nucleic Acids Res. 12, 387-395.
11. Dolly, J. O., Ashton, A. C., Evans, D. M., Richardson, P. J., Black, J. D., and Melling, J. (1987). Molecular action of botulinum neurotoxins: Role of acceptors in targetting to cholinergic nerves and in the inhibition of release of several transmitters, in Cellular and Molecular Basis of Cholinergic Function (Dowdall, M. J., ed.), Ellis Horwood, Chichester, England, pp. 517-533.
12. Eisenberg, D., Schwarz, E., Komaromy, M., and Wall, R. (1984). Analysis of membrane and surface protein sequences with hydrophobic moment plot, J. Mol. Biol. 179, 125-142.
13. Fischmann, T. O., Bentley, G. A., Bhat, T. N., Boulot, G., Mariuzza, R. A., Phillip, S. E. V., Tello, D., and Poljak, R. J. (1991). Crystallographic refinement of the three-dimensional structure of the FabD1.3-lysozyme complex at 2.5-Å resolution, J. Biol. Chem. 266, 12915-12920.
14. Gallis, H. A. (1984). Streptococcus, in Zinsser Microbiology, 18th ed. (Joklik, W. K., Willett, H. P., and Amos, D. B., eds.), Appleton-Century-Crofts, Norwalk, Connecticut, pp. 463-476.
15. Getzoff, E. D., Geysen, H. M., Rodda, S. J., Alexander, H., Tainer, J. A., and Lerner, R. A. (1987). Mechanisms of antibody binding to a protein, Science 235, 1191-1196.
16. Geysen, H. M., Rodda, S. J., Mason, T. J., Tainer, J. A., Alexander, H., Getzoff, E., and Lerner, R. A. (1987a). Response to: Novotný et al., 1987, Science 238, 1584-1586.
17. Geysen, H. M., Tainer, J. A., Rodda, S. J., Masson, T. J., Alexander, H., Getzoff, E., and Lerner, R. A. (1987b). Chemistry of antibody binding to a protein, Science 235, 1184-1190.
18. Jameson, B. A., and Wolf, H. (1988). The antigenic index: A novel algorithm for predicting antigenic determinants, CABIOS 4, 181-186.
19. Kabsch, W., and Sander, C. (1983). Dictionary of protein secondary structure: Pattern recognition of hydrogenbonded and geometrical features, Biopolymers 22, 2577-2637.
20. Kanehisa, M. (1988). IDEAS-88, Integrated Database and Extended Analysis System for Nucleic Acids and Proteins, IDEAS User's Manual, Advanced Scientific Computing Laboratory, National Cancer Institute, Frederick Cancer Research Facility, Frederick, Maryland.
21. Lebeda, F. J., and Olson, M. A. (1994). Secondary structural predictions for the clostridial neurotoxins, Proteins: Struct. Funct. Gen. 20, 293-300.
22. Lebeda, F. J., and Olson, M. A. (1995). Structural predictions of the channel-forming region of botulinum neurototoxin heavy chain, Toxicon 33, 559-567.
23. Lebeda, F. J., Hack, D. C., and Gentry, M. K. (1994). Theoretical analyses of the functional regions of the heavy chain of botulinum neurotoxin, in Therapy with Botulinum Toxin (Jankovic, J., and Hallett, M., eds.), Marcel Dekker, New York, pp. 51-61.
24. Ledoux, D. N., Be, X.-H., and Singh, B. R. (1994). Quaternary structure of botulinum and tetanus neurotoxins as probed by chemical crosslinking and native gel electrophoresis, Toxicon 32, 1095-1104.
25. Makoff, A. J., Ballantine, S. P., Smallwood, A. E., and Fairweather, N. F. (1989). Expression of tetanus toxin fragment C in E. coli: Its purification and potential use as a vaccine, Biotechnology 7, 1043-1046.
26. Middlebrook, J. L. (1994). Development of a molecularly engineered vaccine for botulinum toxin, Toxicon 32, 242.
27. Middlebrook, J. L. (1995). Development of a molecularly engineered vaccine for botulinum toxin, in First International Conference on the Molecular Genetics and Pathogenesis of the Clostridia, p. 16.
28. Montal, M. S., Blewitt, R., Tomich, J. M., and Montal, M. (1992). Identification of an ion channel-forming motif in the primary structure of tetanus and botulinum neurotoxins, FEBS Lett. 313, 12-18.
29. Novotny, J., and Auffray, C. (1984). A program for prediction of protein secondary structure from nucleic sequence data: Application to histocompatibility antigens. Nucleic Acids Res. 12, 243-255.
30. Novotný, J., Handschumacher, M., Haber, E., Bruccoleri, R. E., Carlson, W. B., Fanning, D. W., Smith, J. A., and Rose, G. D. (1986). Antigenic determinants in proteins coincide with surface regions accessible to large probes (antibody domains), Proc. Natl. Acad. Sci. USA 83, 226-230.
31. Novotný, J., Bruccoleri, R. E., Carlson, W. D., Handschumacher, M., and Haber, E. (1987). Antigenicity of myohemerythrin, Science 238:1584.
32. Padlan, E. A., Silverton, E. W., Sheriff, S., Cohen, G. H., Smith-Gill, S. J., and Davies, D. R. (1989). Structure of an antibody-antigen complex: Crystal structure of the HyHEL-10 Fab-lysozyme complex, Proc. Natl. Acad. Sci. USA 86, 5938-5942.
33. Rost, B., and Sander, C. (1993). Prediction of protein secondary structure at better than 70% accuracy, J. Mol. Biol. 232, 584-599.
34. Rost, B., and Sander, C. (1994a). Combining evolutionary information and neural networks to predict protein secondary structure, Proteins: Struct. Funct. Gen. 19, 55-72.
35. Rost, B., and Sander, C. (1994b). Conservation and prediction of solvent accessibility in protein families, Proteins: Struct. Funct. Gen. 20, 216-226.
36. Sander, C., and Schneider, R. (1991). Database of homology-derived structures and the structural meaning of sequence alignment, Proteins: Struct. Funct. Gen. 9, 56-68.
37. Schiavo, G., Rossetto, O., and Montecucco, C. (1994). Clostridial neurotoxins as tools to investigate the molecular events of neurotransmitter release, Semin. Cell Biol. 5, 221-229.
38. Schuler, G. D., Altschul, S. F., and Lipman, D. J. (1991). A workbench for multiple alignment construction and analysis, Proteins: Struct. Funct. Gen. 9, 180-190.
39. Sheriff, T., Silverton, E. W., Padlan, E. A., Cohen, G. H., Smith-Gill, S. J., Finzel, B. C., and Davies, D. R. (1987). Three-dimensional structure of an antibody-antigen complex, Proc. Natl. Acad. Sci. USA 84, 8075-8079.
40. Simpson, L. L. (1984). The binding fragment from tetanus toxin antagonizes the neuromuscular blocking actions of botulinum toxin, J. Pharmacol. Exp. Ther. 229, 182-187.
41. Smith, L. A., Zuber, M., and Hoover, T. A. (1995). The protective efficacy of recombinant truncated Hc from Clostridium botulinum neurotoxin A, in First International Conference on the Molecular Genetics and Pathogenesis of the Clostridia, p. 23.
42. Thornton, J. M., Edwards, M. S., Taylor, W. R., and Barlow, D. J. (1986). Location of 'continuous' antigenic determinants in the protruding regions of proteins, EMBO J. 5, 409-413.
43. VanCott, T. C., Bethke, F. R., Artenstein, A. W., McCutchan, F. E., McNeil, J. G., Mascola, J. R., Redfield, R. R., and Birx, D. L. (1994). Serotyping international HIV-1 isolates by V3 peptides and whole gp120 proteins using BIAcore, Methods: Companion Meth. Enzymol. 6, 188-198.